Formulation, characterization, and expression of a recombinant MOMP Chlamydia trachomatis DNA vaccine encapsulated in chitosan nanoparticles
Authors:
- Vida DennisVDVida Dennis
- Shree R SinghSSShree R Singh
- Alain B WaffoAWAlain B Waffo
- Stacie J FairleySFStacie J Fairley
Open Access
- 1 May 2013
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. 8 (1) , 1759-1771
Abstract
Chlamydia trachomatis is a bacterial sexually transmitted infection affecting millions of people worldwide. Previous vaccination attempts have employed the recombinant major outer membrane protein (MOMP) of C. trachomatis nonetheless, with limited success, perhaps, due to stability, degradation, and delivery issues. In this study we cloned C. trachomatis recombinant MOMP DNA (DMOMP) and encapsulated it in chitosan nanoparticles (DMCNP) using the complex coacervation technique. Physiochemical characterizations of DMCNP included transmission and scanning electron microcopy, Fourier transform infrared and ultraviolet-visible spectroscopy, and zeta potential. Encapsulated DMOMP was 167–250 nm, with a uniform spherical shape and homogenous morphology, and an encapsulation efficiency > 90%. A slow release pattern of encapsulated DMOMP, especially in acidic solution, was observed over 7 days. The zeta potential of DMCNP was ~8.80 mV, which indicated that it was highly stable. Toxicity studies of DMCNP (25–400 µg/mL) to Cos-7 cells using the MTT assay revealed minimal toxicity over 24–72 hours with >90% viable cells. Ultra-violet visible (UV-vis) spectra indicated encapsulated DMOMP protection by chitosan, whereas agarose gel electrophoresis verified its protection from enzymatic degradation. Expression of MOMP protein in DMCNP-transfected Cos-7 cells was demonstrated via Western blotting and immunofluorescence microscopy. Significantly, intramuscular injection of BALB/c mice with DMCNP confirmed the delivery of encapsulated DMOMP, and expression of the MOMP gene transcript in thigh muscles and spleens. Our data show that encapsulation of DMOMP in biodegradable chitosan nanoparticles imparts stability and protection from enzymatic digestion, and enhances delivery and expression of DMOMP in vitro and in mice. Further investigations of the nanoencapsulated DMCNP vaccine formulation against C. trachomatis in mice are warranted.Keywords
This publication has 48 references indexed in Scilit:
- Formulation andin vitrocharacterization of PEGylated chitosan and polyethylene imine polymers with thrombospondin‐I gene bearing pDNAJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2012
- Protective immunity against Chlamydia trachomatis genital infection induced by a vaccine based on the major outer membrane multi-epitope human papillomavirus major capsid protein L1Vaccine, 2011
- Development of a Chlamydia trachomatis T cell VaccineHuman Vaccines, 2010
- Enhanced delivery and expression of a nanoencapsulated DNA vaccine vector for respiratory syncytial virusNanomedicine: Nanotechnology, Biology and Medicine, 2009
- Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane proteinVaccine, 2009
- Identification and characterization of novel recombinant vaccine antigens for immunization against genitalChlamydia trachomatisFEMS Immunology & Medical Microbiology, 2009
- Encapsulation of proteins and peptides into biodegradable poly(d,l-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cellsVaccine, 2006
- Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infectionVaccine, 2005
- PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccinesAdvanced Drug Delivery Reviews, 2005
- T-Cell Epitopes in Variable Segments ofChlamydia trachomatisMajor Outer Membrane Protein Elicit Serovar-Specific Immune Responses in Infected HumansInfection and Immunity, 2000